secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2023-01-12T23:59:59+00:00
Accession:  0001193125-23-007281
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

TXMD receives Nasdaq deficiency notice for missing annual meeting; has 45 days to submit compliance plan
--------------------------------------------------------------------------------

- Received Nasdaq deficiency letter on Jan 6, 2023 for failing to hold 2022 annual meeting within 12 months of FYE Dec 31, 2021.
- No immediate effect on listing; TXMD has until Feb 20, 2023 to submit a plan to regain compliance.
- If plan accepted, Nasdaq may grant extension until June 29, 2023 to hold annual meeting.
- Company intends to submit a plan and hold the 2022 annual meeting before June 29, 2023.
- If plan rejected, TXMD can appeal to a Hearings Panel; listing would remain pending decision.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000119312523007281/0001193125-23-007281-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000119312523007281/d446951d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-007281

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer